(Q54562715)

English

Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia.

scientific article published on 15 September 2011

Statements

Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit